129 related articles for article (PubMed ID: 14534292)
1. Identification of selective inhibitors of NAD+-dependent deacetylases using phenotypic screens in yeast.
Hirao M; Posakony J; Nelson M; Hruby H; Jung M; Simon JA; Bedalov A
J Biol Chem; 2003 Dec; 278(52):52773-82. PubMed ID: 14534292
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of Sir2 inhibitors through phenotypic assays in yeast.
Posakony J; Hirao M; Bedalov A
Comb Chem High Throughput Screen; 2004 Nov; 7(7):661-8. PubMed ID: 15578928
[TBL] [Abstract][Full Text] [Related]
3. Identification of a small molecule inhibitor of Sir2p.
Bedalov A; Gatbonton T; Irvine WP; Gottschling DE; Simon JA
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15113-8. PubMed ID: 11752457
[TBL] [Abstract][Full Text] [Related]
4. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
Borra MT; Langer MR; Slama JT; Denu JM
Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of Sir2: evaluation of splitomicin analogues.
Posakony J; Hirao M; Stevens S; Simon JA; Bedalov A
J Med Chem; 2004 May; 47(10):2635-44. PubMed ID: 15115404
[TBL] [Abstract][Full Text] [Related]
6. Use of substrate analogs and mutagenesis to study substrate binding and catalysis in the Sir2 family of NAD-dependent protein deacetylases.
Khan AN; Lewis PN
J Biol Chem; 2006 Apr; 281(17):11702-11. PubMed ID: 16520376
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors.
Mai A; Massa S; Lavu S; Pezzi R; Simeoni S; Ragno R; Mariotti FR; Chiani F; Camilloni G; Sinclair DA
J Med Chem; 2005 Dec; 48(24):7789-95. PubMed ID: 16302818
[TBL] [Abstract][Full Text] [Related]
8. Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition.
Sauve AA; Moir RD; Schramm VL; Willis IM
Mol Cell; 2005 Feb; 17(4):595-601. PubMed ID: 15721262
[TBL] [Abstract][Full Text] [Related]
9. Swapping the gene-specific and regional silencing specificities of the Hst1 and Sir2 histone deacetylases.
Mead J; McCord R; Youngster L; Sharma M; Gartenberg MR; Vershon AK
Mol Cell Biol; 2007 Apr; 27(7):2466-75. PubMed ID: 17242192
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of splitomicin analogs targeted at human NAD(+)-dependent histone deacetylases (sirtuins).
Freitag M; Schemies J; Larsen T; El Gaghlab K; Schulz F; Rumpf T; Jung M; Link A
Bioorg Med Chem; 2011 Jun; 19(12):3669-77. PubMed ID: 21315612
[TBL] [Abstract][Full Text] [Related]
11. [Chemistry and biology of NAD-dependent deacetylases].
Simon JA; Hirao M
Tanpakushitsu Kakusan Koso; 2005 Aug; 50(9):1049-55. PubMed ID: 16083042
[No Abstract] [Full Text] [Related]
12. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening.
Grozinger CM; Chao ED; Blackwell HE; Moazed D; Schreiber SL
J Biol Chem; 2001 Oct; 276(42):38837-43. PubMed ID: 11483616
[TBL] [Abstract][Full Text] [Related]
13. The Sir2 family of protein deacetylases.
Blander G; Guarente L
Annu Rev Biochem; 2004; 73():417-35. PubMed ID: 15189148
[TBL] [Abstract][Full Text] [Related]
14. HST1, a new member of the SIR2 family of genes.
Derbyshire MK; Weinstock KG; Strathern JN
Yeast; 1996 Jun; 12(7):631-40. PubMed ID: 8810037
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for the NAD-dependent deacetylase mechanism of Sir2.
Chang JH; Kim HC; Hwang KY; Lee JW; Jackson SP; Bell SD; Cho Y
J Biol Chem; 2002 Sep; 277(37):34489-98. PubMed ID: 12091395
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.
Imai S; Armstrong CM; Kaeberlein M; Guarente L
Nature; 2000 Feb; 403(6771):795-800. PubMed ID: 10693811
[TBL] [Abstract][Full Text] [Related]
17. Structure of the histone deacetylase SIRT2.
Finnin MS; Donigian JR; Pavletich NP
Nat Struct Biol; 2001 Jul; 8(7):621-5. PubMed ID: 11427894
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.
Zhao K; Harshaw R; Chai X; Marmorstein R
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8563-8. PubMed ID: 15150415
[TBL] [Abstract][Full Text] [Related]
19. SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates.
Sauve AA; Schramm VL
Curr Med Chem; 2004 Apr; 11(7):807-26. PubMed ID: 15078167
[TBL] [Abstract][Full Text] [Related]
20. SIR2 family of NAD(+)-dependent protein deacetylases.
Smith JS; Avalos J; Celic I; Muhammad S; Wolberger C; Boeke JD
Methods Enzymol; 2002; 353():282-300. PubMed ID: 12078503
[No Abstract] [Full Text] [Related]
[Next] [New Search]
